학술논문
Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The AVENUE Phase 2 Randomized Clinical Trial.
Document Type
journal article
Author
Source
JAMA Ophthalmology; Sep2020, Vol. 138 Issue 9, p955-963, 9p
Subject
Language
ISSN
21686165